Ge Jiang
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Protein purification and stability 3
- Advanced biosensing and bioanalysis techniques 3
- Bacillus and Francisella bacterial research 3
-
- Advanced Drug Delivery Systems 7
- Co-authors
- Patrick P. DeLuca (7 shared papers)Sei Kwang Hahn (5 shared papers)Ki Su Kim (3 shared papers)Jiseok Kim (3 shared papers)Kitae Park (2 shared papers)Byung Ho Woo (3 shared papers)Eun Ju Oh (3 shared papers)Yeong Woo Jo (2 shared papers)
- Journals
- Pharmaceutical Research (5 papers)Biopolymers (2 papers)International Journal of Pharmaceutics (2 papers)Scientific Reports (1 paper)ESMO Open (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ge Jiang
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Pharmaceutical Science 405
- Biomaterials 324
- Molecular Medicine 92
- Molecular Biology 554
- Urology 44
Countries citing papers authored by Ge Jiang
This map shows the geographic impact of Ge Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Jiang more than expected).
Fields of papers citing papers by Ge Jiang
This network shows the impact of papers produced by Ge Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Jiang. The network helps show where Ge Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ge Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 145 | |
| 2 | 2001 | 138 | |
| 3 | 2008 | 129 | |
| 4 | 2004 | 117 | |
| 5 | 2007 | 87 | |
| 6 | 2017 | 84 | |
| 7 | 2002 | 84 | |
| 8 | 2003 | 78 | |
| 9 | 2002 | 75 | |
| 10 | 2001 | 75 | |
| 11 | 2003 | 64 | |
| 12 | 2005 | 63 | |
| 13 | 2008 | 59 | |
| 14 | 2007 | 41 | |
| 15 | 2007 | 32 | |
| 16 | 2004 | 32 | |
| 17 | 2002 | 26 | |
| 18 | Alginate/PEI/DNA polyplexes: a new gene delivery system. | 2006 | 20 |
| 19 | 2024 | 17 | |
| 20 | 2019 | 10 |
About Ge Jiang
Ge Jiang is a scholar working on Molecular Biology, Pharmaceutical Science, Genetics, Biomedical Engineering and Biomaterials, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (7 papers), RNA Interference and Gene Delivery (5 papers), Protein purification and stability (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Bacillus and Francisella bacterial research (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (405 citations), Biomaterials (324 citations), Molecular Medicine (92 citations), Molecular Biology (554 citations) and Urology (44 citations). Ge Jiang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Patrick P. DeLuca, Sei Kwang Hahn, Ki Su Kim, Jiseok Kim, Kitae Park, Byung Ho Woo, Eun Ju Oh, Yeong Woo Jo, B. C. Thanoo and Wei Qiu. Their work appears in journals such as Pharmaceutical Research, Biopolymers, International Journal of Pharmaceutics, Scientific Reports and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.